Literature DB >> 32047917

Using Open Questions to Understand 650 People's Experiences With Antipsychotic Drugs.

John Read1, Ann Sacia1.   

Abstract

Studies of antipsychotic medication, which are increasingly prescribed for a broad range of problems and circumstances, rarely ask the people who take them to describe their experiences with the drugs. In this study, 650 people, from 29 countries, responded, in an online survey, to "Overall in my life antipsychotic medications have been _____?" and "Is there anything else you would like to say, or emphasise, about your experiences with antipsychotic drugs?" Of the total participants, 14.3% were categorized as reporting purely positive experiences, 27.9% had mixed experiences, and 57.7% reported only negative ones. Negative experiences were positively correlated with age. Thematic analysis identified 749 negative, 180 positive, and 53 mixed statements. The 2 positive themes were "symptom reduction" (14) and "sleep" (14), with the majority (153) unspecified. The 4 negative themes (besides "unspecified"-191) were: "adverse effects" (316), "interactions with prescriber" (169), "withdrawal/difficult to get off them" (62), and "ineffective" (11). The adverse effects included: weight gain, emotional numbing, cognitive dysfunction, sedation, akathisia, effects on relationships, and suicidality. "Interactions with prescriber" included lack of information about withdrawal effects, support, or discussion of alternatives. The only mixed theme was "short-term good, long-term bad" (28). Open questions can add to findings from methodologies focused on symptom reduction. Clinicians should pay more attention to the need for respectful and collaborative patient-prescriber relationships. At the point of prescription, this must include providing the full range of information about antipsychotics, including potential benefits and harms, difficulties withdrawing, and information on alternatives treatments such as psychological therapies.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adverse effects; antipsychotics; first person accounts; psychosis; therapeutic relationship; withdrawal effects

Mesh:

Substances:

Year:  2020        PMID: 32047917      PMCID: PMC7345822          DOI: 10.1093/schbul/sbaa002

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  41 in total

1.  Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.

Authors:  Martin Harrow; Thomas H Jobe
Journal:  J Nerv Ment Dis       Date:  2007-05       Impact factor: 2.254

2.  Extrapyramidal side-effects of antipsychotics in a randomised trial.

Authors:  Del D Miller; Stanley N Caroff; Sonia M Davis; Robert A Rosenheck; Joseph P McEvoy; Bruce L Saltz; Silvana Riggio; Miranda H Chakos; Marvin S Swartz; Richard S E Keefe; T Scott Stroup; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2008-10       Impact factor: 9.319

3.  Assessing the Impact and Effectiveness of Hearing Voices Network Self-Help Groups.

Authors:  Eleanor Longden; John Read; Jacqui Dillon
Journal:  Community Ment Health J       Date:  2017-06-21

4.  Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review.

Authors:  Ruth E Cooper; Neelam Laxhman; Nadia Crellin; Joanna Moncrieff; Stefan Priebe
Journal:  Schizophr Res       Date:  2019-05-21       Impact factor: 4.939

5.  A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication.

Authors:  Richard Gray; Diana Rofail; Jon Allen; Tim Newey
Journal:  J Adv Nurs       Date:  2005-10       Impact factor: 3.187

6.  Living with antipsychotic medication side-effects: the experience of Australian mental health consumers.

Authors:  Paul Morrison; Tom Meehan; Norman Jay Stomski
Journal:  Int J Ment Health Nurs       Date:  2014-12-22       Impact factor: 3.503

7.  A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Authors:  Martin Harrow; Thomas H Jobe; Robert N Faull; Jie Yang
Journal:  Psychiatry Res       Date:  2017-06-22       Impact factor: 3.222

8.  Drug-free psychiatric treatment - what do the patients think?

Authors:  Stig Heskestad; Anne Martha Kalhovde; Einar Steen Jakobsen; Margrete Tytlandsvik; Laila Horpestad; Inger Karin Sletthaug Runde
Journal:  Tidsskr Nor Laegeforen       Date:  2019-10-02

9.  Antipsychotic treatment of adults in the United States.

Authors:  Mark Olfson; Marissa King; Michael Schoenbaum
Journal:  J Clin Psychiatry       Date:  2015-10       Impact factor: 4.384

Review 10.  Shared decision making for psychiatric medication management: beyond the micro-social.

Authors:  Nicola Morant; Emma Kaminskiy; Shulamit Ramon
Journal:  Health Expect       Date:  2015-08-10       Impact factor: 3.377

View more
  6 in total

Review 1.  Progress in mechanistically novel treatments for schizophrenia.

Authors:  James Neef; Daniel S Palacios
Journal:  RSC Med Chem       Date:  2021-06-29

2.  Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication.

Authors:  Miriam Larsen-Barr; Fred Seymour
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-31

3.  Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review.

Authors:  Marius H Sneller; Nini de Boer; Sophie Everaars; Max Schuurmans; Sinan Guloksuz; Wiepke Cahn; Jurjen J Luykx
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

4.  Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS.

Authors:  Seth C Hopkins; Ajay Ogirala; MaryAlice Worden; Kenneth S Koblan
Journal:  Clin Drug Investig       Date:  2021-11-09       Impact factor: 2.859

5.  The experiences of 585 people when they tried to withdraw from antipsychotic drugs.

Authors:  John Read
Journal:  Addict Behav Rep       Date:  2022-03-17

6.  Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia.

Authors:  Johannes Lieslehto; Jari Tiihonen; Markku Lähteenvuo; Antti Tanskanen; Heidi Taipale
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.